seekingalpha.com
/1 week ago
Latest updates for Nrxp
Fresh curated links around NRXP are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
- NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty
- Axonics
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 week ago
NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty
cafepharma.com
/1 month ago
Axonics
Axonics Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...
cafepharma.com
/3 weeks ago
Axonics
Axonics Anonymous (not verified) Sat, 05/09/2026 - 08:22 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...
finance.yahoo.com
/1 month ago
Recursion Pharmaceuticals (RXRX) Offers Encouraging Prospects After Setting 2026 Priorities
newswire.com
/1 month ago
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Pe...
Sponsored Programming Supported by Commercials from Medicus Pharma (NASDAQ:MDCX), IGC Pharma (NYSE American:IGC), Roadzen (NASDAQ:RDZN), and Lantern Pharma (NASDAQ:LTRN)
fool.com
/2 weeks ago
NeuroPace (NPCE) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DateTuesday, May 12, 2026 at 4:30 p.m. ET Call participantsChief Executive Officer — Joel D. BeckerChief Financial Officer — Patrick F. WilliamsNeed...
newswire.com
/1 month ago
NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study
NX Development Corp (NXDC) submits an sNDA to the FDA for Gleolan based on the MEN-301 study to improve visualization during meningioma surgery. Learn more.
seekingalpha.com
/2 weeks ago
Xencor, Inc. (XNCR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
cafepharma.com
/13 hours ago
Argenx
Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
finance.yahoo.com
/2 weeks ago
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
fool.com
/10 hours ago
RXO Stock Has Surged 75% Since This Fund Made a $10 Million Bet
RXO uses a digital freight marketplace to deliver asset-light logistics and transportation solutions across multiple U.S. industries.
investing.com
/3 weeks ago
Nexi reports first quarter revenue growth amid mixed segment performance
seekingalpha.com
/3 weeks ago
Nexi S.p.A. 2026 Q1 - Results - Earnings Call Presentation
seekingalpha.com
/1 month ago
Nexity SA (NNXXY) Q1 2026 Sales/ Trading Statement Call - Slideshow
seekingalpha.com
/1 month ago
Nektar Therapeutics: 'Strong Buy' On REZPEG POC Established In AD/AA And Late-Stage Development
fool.com
/2 weeks ago
Nexgel (NXGL) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEFriday, May 15, 2026 at 12 p.m. ETCALL PARTICIPANTSChief Executive Officer — Adam R. LevyChief Financial Officer — Ian BlackmanNeed a quote from...
fool.com
/2 weeks ago
Nexgel (NXGL) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEFriday, May 15, 2026 at 12 p.m. ETCALL PARTICIPANTSChief Executive Officer — Adam R. LevyChief Financial Officer — Ian BlackmanNeed a quote from...
seekingalpha.com
/1 month ago
Rexford Industrial Realty, Inc. (REXR) Q1 2026 Earnings Call Transcript
seekingalpha.com
/1 month ago
Inhibrx: Spinoff Rumors Send Shares Soaring - Stunning Bull Run Can Continue
cafepharma.com
/3 weeks ago
Revolution Medicines
Revolution Medicines Anonymous (not verified) Tue, 05/05/2026 - 02:20 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...
seekingalpha.com
/2 weeks ago
Immuneering Corporation: Updates Inbound At The End Of The Month
seekingalpha.com
/1 month ago
Compass Therapeutics, Inc. (CMPX) Discusses Positive Secondary Endpoint Results From COMPANION-002 Study in Advanced Bil...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Nrxp
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source
investing.com
Recent coverage from public sources
Public source